Urology Partners of North Texas Trials

Urology Partners of North Texas	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

White, Amanda

UNCOVER, NCT04753385: The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes

Terminated

N/A

138

LivaNova

Treatment Resistant Depression

09/24

RECOVER, NCT03887715: A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Recruiting

N/A

6800

Vagus Nerve Stimulation (VNS), VNS

LivaNova

Treatment Resistant Depression

02/28

12/30

Padron, Osvaldo

STREAM, NCT05383274: Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

Recruiting

Optilume Urethral DCB

Urotronic Inc., Laborie Medical Technologies Inc.

Urethral Stricture

12/25

12/26

NCT05375903: A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Active, not recruiting

Europe, US

UGN-301, UGN-301 (zalifrelimab) intravesical solution, UGN-201, UGN-201 (imiquimod) intravesical solution, Gemcitabine

UroGen Pharma Ltd.

Non-muscle Invasive Bladder Cancer, NMIBC, Carcinoma in Situ of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder, Urothelial Carcinoma Recurrent

12/25

PURSUIT, NCT04720352: Prospective US Radiofrequency SUI Trial

Recruiting

N/A

390

Active treatment, Sham

Viveve Inc.

Urinary Incontinence, Stress

12/22

NCT05010759: Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer

Terminated

N/A

NanoTherm Ablation

MagForce USA

Prostate Cancer

07/23

PEAK, NCT06312722: Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

Recruiting

N/A

Optilume® BPH Catheter System

Urotronic Inc.

Benign Prostatic Hyperplasia

02/31

NCT06217328: RESTORE: An RCT to Evaluate the Efficacy of the Revi System

Recruiting

N/A

150

Revi System Treatment, Revi System - Delayed Activation

BlueWind Medical

Urinary Urge Incontinence

05/26

05/27

APEX, NCT06560476: OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

Recruiting

N/A

500

Data collection

Urotronic Inc.

Benign Prostatic Hyperplasia

03/27

NCT02577302: CAN-Stim Compared to SNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology

Recruiting

N/A

200

CAN-Stim - Protect CAN-Stim System, SNS - InterStim® System

Uro Medical Corporation

Urinary Incontinence, Urge

10/25

Robinson, Tracey

NCT06217328: RESTORE: An RCT to Evaluate the Efficacy of the Revi System

Recruiting

N/A

150

Revi System Treatment, Revi System - Delayed Activation

BlueWind Medical

Urinary Urge Incontinence

05/26

05/27

VAPOR 2, NCT05683691: Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer

Active, not recruiting

N/A

400

Vanquish System

Francis Medical Inc.

Prostate Cancer

04/27

04/29

Xavier, Keith

TITAN 2, NCT05226286: Evaluation of Implantable Tibial Neuromodulation Pivotal Study

Active, not recruiting

N/A

188

Medtronic Implantable Tibial Neuromodulation (TNM) System

MedtronicNeuro

Overactive Bladder

10/23

05/25

NCT06217328: RESTORE: An RCT to Evaluate the Efficacy of the Revi System

Recruiting

N/A

150

Revi System Treatment, Revi System - Delayed Activation

BlueWind Medical

Urinary Urge Incontinence

05/26

05/27

NCT05959655: Modern Urodynamics System Efficacy (MUSE) Study

Completed

N/A

Glean Urodynamics System, GUS

Bright Uro

Urologic Diseases, Urodynamics

04/24

Michaud, Beth

TITAN 2, NCT05226286: Evaluation of Implantable Tibial Neuromodulation Pivotal Study

Active, not recruiting

N/A

188

Medtronic Implantable Tibial Neuromodulation (TNM) System

MedtronicNeuro

Overactive Bladder

10/23

05/25

Cannon-Smith, Tracy

NCT05959655: Modern Urodynamics System Efficacy (MUSE) Study

Completed

N/A

Glean Urodynamics System, GUS

Bright Uro

Urologic Diseases, Urodynamics

04/24

RECIPE, NCT05685433: A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation

Recruiting

N/A

200

eCoin Tibial Nerve Stimulation

Valencia Technologies Corporation

Overactive Bladder, Urge Incontinence, Incontinence, Urinary, Urinary Urge Incontinence

08/25

12/30

Harandi, Arshia Aalami

NCT05959655: Modern Urodynamics System Efficacy (MUSE) Study

Completed

N/A

Glean Urodynamics System, GUS

Bright Uro

Urologic Diseases, Urodynamics

04/24

Alvarez, Alonso

NCT06217328: RESTORE: An RCT to Evaluate the Efficacy of the Revi System

Recruiting

N/A

150

Revi System Treatment, Revi System - Delayed Activation

BlueWind Medical

Urinary Urge Incontinence

05/26

05/27

APEX, NCT06560476: OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

Recruiting

N/A

500

Data collection

Urotronic Inc.

Benign Prostatic Hyperplasia

03/27

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

White, Amanda

UNCOVER, NCT04753385: The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes

Terminated

N/A

138

LivaNova

Treatment Resistant Depression

09/24

Recruiting

N/A

6800

Vagus Nerve Stimulation (VNS), VNS

LivaNova

Treatment Resistant Depression

02/28

12/30

Padron, Osvaldo

STREAM, NCT05383274: Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

Recruiting

Optilume Urethral DCB

Urotronic Inc., Laborie Medical Technologies Inc.

Urethral Stricture

12/25

12/26

NCT05375903: A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Active, not recruiting

Europe, US

UGN-301, UGN-301 (zalifrelimab) intravesical solution, UGN-201, UGN-201 (imiquimod) intravesical solution, Gemcitabine

UroGen Pharma Ltd.

Non-muscle Invasive Bladder Cancer, NMIBC, Carcinoma in Situ of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder, Urothelial Carcinoma Recurrent

12/25

PURSUIT, NCT04720352: Prospective US Radiofrequency SUI Trial

Recruiting

N/A

390

Active treatment, Sham

Viveve Inc.

Urinary Incontinence, Stress

12/22

NCT05010759: Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer

Terminated

N/A

NanoTherm Ablation

MagForce USA

Prostate Cancer

07/23

PEAK, NCT06312722: Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

Recruiting

N/A

Optilume® BPH Catheter System

Urotronic Inc.

Benign Prostatic Hyperplasia

02/31

NCT06217328: RESTORE: An RCT to Evaluate the Efficacy of the Revi System

Recruiting

N/A

150

Revi System Treatment, Revi System - Delayed Activation

BlueWind Medical

Urinary Urge Incontinence

05/26

05/27

APEX, NCT06560476: OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

Recruiting

N/A

500

Data collection

Urotronic Inc.

Benign Prostatic Hyperplasia

03/27

NCT02577302: CAN-Stim Compared to SNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology

Recruiting

N/A

200

CAN-Stim - Protect CAN-Stim System, SNS - InterStim® System

Uro Medical Corporation

Urinary Incontinence, Urge

10/25

Robinson, Tracey

NCT06217328: RESTORE: An RCT to Evaluate the Efficacy of the Revi System

Recruiting

N/A

150

Revi System Treatment, Revi System - Delayed Activation

BlueWind Medical

Urinary Urge Incontinence

05/26

05/27

VAPOR 2, NCT05683691: Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer

Active, not recruiting

N/A

400

Vanquish System

Francis Medical Inc.

Prostate Cancer

04/27

04/29

Xavier, Keith

TITAN 2, NCT05226286: Evaluation of Implantable Tibial Neuromodulation Pivotal Study

Active, not recruiting

N/A

188

Medtronic Implantable Tibial Neuromodulation (TNM) System

MedtronicNeuro

Overactive Bladder

10/23

05/25

NCT06217328: RESTORE: An RCT to Evaluate the Efficacy of the Revi System

Recruiting

N/A

150

Revi System Treatment, Revi System - Delayed Activation

BlueWind Medical

Urinary Urge Incontinence

05/26

05/27

NCT05959655: Modern Urodynamics System Efficacy (MUSE) Study

Completed

N/A

Glean Urodynamics System, GUS

Bright Uro

Urologic Diseases, Urodynamics

04/24

Michaud, Beth

TITAN 2, NCT05226286: Evaluation of Implantable Tibial Neuromodulation Pivotal Study

Active, not recruiting

N/A

188

Medtronic Implantable Tibial Neuromodulation (TNM) System

MedtronicNeuro

Overactive Bladder

10/23

05/25

Cannon-Smith, Tracy

NCT05959655: Modern Urodynamics System Efficacy (MUSE) Study

Completed

N/A

Glean Urodynamics System, GUS

Bright Uro

Urologic Diseases, Urodynamics

04/24

RECIPE, NCT05685433: A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation

Recruiting

N/A

200

eCoin Tibial Nerve Stimulation

Valencia Technologies Corporation

Overactive Bladder, Urge Incontinence, Incontinence, Urinary, Urinary Urge Incontinence

08/25

12/30

Harandi, Arshia Aalami

NCT05959655: Modern Urodynamics System Efficacy (MUSE) Study

Completed

N/A

Glean Urodynamics System, GUS

Bright Uro

Urologic Diseases, Urodynamics

04/24

Alvarez, Alonso

NCT06217328: RESTORE: An RCT to Evaluate the Efficacy of the Revi System

Recruiting

N/A

150

Revi System Treatment, Revi System - Delayed Activation

BlueWind Medical

Urinary Urge Incontinence

05/26

05/27

APEX, NCT06560476: OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

Recruiting

N/A

500

Data collection

Urotronic Inc.

Benign Prostatic Hyperplasia

03/27



	Diseases Companies Products Productz Mechanisms of Action Sites